Jason L. Vassy, MD, MPH

Adjunct Assistant Professor, Medicine

Jason Vassy
617.638.5300
150 S Huntington Avenue

Other Positions

  • VA Boston Healthcare System

Education

  • Washington University School of Medicine, MD
  • Johns Hopkins University School of Public Health, MPH
  • Furman University, BS
  • Harvard School of Public Health, SM/ScM

Publications

  • Published on 10/5/2018

    Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, Biswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM, Everett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston JJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J, Plon SE, Rehm HL, Richards CS, Romasko EJ, Miren Sagardia A, Spinner NB, Thompson ML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker LG, Hindorff LA. Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. Genet Med. 2018 Oct 05. PMID: 30287922.

    Read at: PubMed
  • Published on 8/23/2018

    Vassy JL, Chun S, Advani S, Ludin SA, Smith JG, Alligood EC. Impact of SLCO1B1 pharmacogenetic testing on patient and healthcare outcomes: A systematic review. Clin Pharmacol Ther. 2018 Aug 23. PMID: 30137643.

    Read at: PubMed
  • Published on 6/1/2018

    Vassy JL, Stone A, Callaghan JT, Mendes M, Meyer LJ, Pratt VM, Przygodzki RM, Scheuner MT, Wang-Rodriguez J, Schichman SA. Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee. Genet Med. 2018 Jun 01. PMID: 29858578.

    Read at: PubMed
  • Published on 4/18/2018

    Vassy JL, Hivert MF, Porneala B, Dauriz M, Florez JC, Dupuis J, Siscovick DS, Fornage M, Rasmussen-Torvik LJ, Bouchard C, Meigs JB. Erratum. Polygenic Type 2 Diabetes Prediction at the Limit of Common Variant Detection. Diabetes 2014;63:2172-2182. Diabetes. 2018 06; 67(6):1206. PMID: 29669744.

    Read at: PubMed
  • Published on 3/22/2018

    Christensen KD, Vassy JL, Phillips KA, Blout CL, Azzariti DR, Lu CY, Robinson JO, Lee K, Douglas MP, Yeh JM, Machini K, Stout NK, Rehm HL, McGuire AL, Green RC, Dukhovny D. Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial. Genet Med. 2018 Mar 22. PMID: 29565423.

    Read at: PubMed
  • Published on 1/26/2018

    Vassy JL, Davis JK, Kirby C, Richardson IJ, Green RC, McGuire AL, Ubel PA. How Primary Care Providers Talk to Patients about Genome Sequencing Results: Risk, Rationale, and Recommendation. J Gen Intern Med. 2018 Jun; 33(6):877-885. PMID: 29374360.

    Read at: PubMed
  • Published on 1/5/2018

    Vassy JL, He W, Florez JC, Meigs JB, Grant RW. Six-Year Diabetes Incidence After Genetic Risk Testing and Counseling: A Randomized Clinical Trial. Diabetes Care. 2018 Mar; 41(3):e25-e26. PMID: 29305403.

    Read at: PubMed
  • Published on 1/3/2018

    Vassy JL, Ho YL, Honerlaw J, Cho K, Gaziano JM, Wilson PWF, Gagnon DR. Yield and bias in defining a cohort study baseline from electronic health record data. J Biomed Inform. 2018 Feb; 78:54-59. PMID: 29305952.

    Read at: PubMed
  • Published on 1/1/2018

    Hull LE, Vassy JL. Toward greater understanding of patient decision-making around genome sequencing. Per Med. 2018 Jan; 15(1):57-66. PMID: 29714114.

    Read at: PubMed
  • Published on 6/27/2017

    Vassy JL, Christensen KD, Schonman EF, Blout CL, Robinson JO, Krier JB, Diamond PM, Lebo M, Machini K, Azzariti DR, Dukhovny D, Bates DW, MacRae CA, Murray MF, Rehm HL, McGuire AL, Green RC. The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. Ann Intern Med. 2017 Jun 27. PMID: 28654958.

    Read at: PubMed

View 39 more publications: View full profile at BUMC

View all profiles